Drug intelligence / Profile preview

P2Et

Development stage
Phase 3
Lead developer
Pontificia Universidad Javeriana
Modality
Small Molecules
Administration
Oral
01

Overview

P2Et is a standardized plant extract derived from Caesalpinia spinosa, rich in gallotannins and other polyphenols. It exhibits potent antioxidant activity and has demonstrated antitumor effects in preclinical models of breast cancer and melanoma. Mechanistically, P2Et induces immunogenic cell death in tumor cells by promoting mitochondrial depolarization and apoptosis, leading to the expression of immunogenic markers such as calreticulin, HMGB1, and ATP. This process enhances dendritic cell activation and stimulates a robust adaptive immune response characterized by increased memory T lymphocytes producing IFN-gamma, TNF-alpha, IL-2, IL-4, and IL-5. In animal models, it reduces primary tumor growth and metastasis while modulating the tumor microenvironment—specifically decreasing serum IL-6 levels associated with protumorigenic fibroblast activity. Clinical studies are evaluating its safety and efficacy as an adjunct to chemotherapy (notably anthracyclines) in breast cancer patients[4][5][2].

Brand names
P2EtP-2EtP 2Et
Other names
Caesalpinia spinosa extractP2Et extractP-2Et extractP 2Et extract

Beyond the preview

Go deeper on P2Et.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P2Et.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call